Colon Surgery Better at NCI Hospital
Posted on: Monday, 28 April 2008, 15:00 CDT
Having colon or rectal cancer surgery at a National Cancer Institute-designated hospital greatly improves short- and long-term survival, a U.S. study found.
Researchers at the University of Pennsylvania School of Medicine in Philadelphia found having colon or rectal surgeries at one of the country's hospitals designated by the National Cancer Institute was linked to a lowered risk of postoperative death and improved long-term survival rates.
Study leader Dr. Najjia Mahmoud and colleagues used National Cancer Institute Surveillance Epidemiological and End Result from more than 52,000 patients across the United States from 1996 to 2003.
The findings, presented at the American Surgical Association Annual Meeting in New York, are scheduled to be published in the Annals of Surgery later in the year.
The researchers suggest possible reasons for the improved short- and long-term outcomes for colon and rectal surgeries at National Cancer Institute-designated facilities may include surgeon training, multi-disciplinary care and adherence to treatment guidelines. The researchers said studies are underway to further clarify the factors leading to improved patient outcomes
Source: United Press International
Related Articles
- GlobeImmune Signs CRADA With the National Institutes of Health to Develop Cancer Therapeutics
- Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke
- EvoGenix to Collaborate With US National Institutes of Health
- The National Institute on Aging Awards Velcura Therapeutics(R), Inc. A SBIR Grant to Further Research Into Process Involved in Human Bone Formation
- Can-Fite BioPharma Signed a Cooperative Research and Development Agreement (CRADA) With the U.S. National Institute of Health (NIH)
- American Institutes for Research Establishes National High School Center, Launches Web Site at Http://Www.Betterhighschools.Org
- National Human Genome Research Institute to Help Develop Lifesaving DNA Tests
- Hemispherx Biopharma Signs Research Agreement With Japanese National Institute of Infectious Disease; Ampligen(R) Sought As Adjuvant for Nasal Flu Vaccine
- National Institute of Mental Health Awards $3 Million Research Grant to PORTALS and Social Work Researchers From USC and UCLA
- UK National Institute for Clinical Excellence Backs the Use of HIFU for the Treatment of Localized Prostate Cancer
 |
 |
User Comments (0)
RSS Feeds